By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Pharmaceutical development business961.06M100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
China629.97M65.55%
Japan331.09M34.45%